Artwork

Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 100: Colorectal Cancer Series, Pt. 2 - Adjuvant Therapy in Stage III Colon Cancer

 
Share
 

Manage episode 414306934 series 3377633
Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week, we kick off our discussion of adjuvant systemic treatment in colon cancer, beginning with Stage III colon cancer. We will review the evidence basis for adjuvant therapy as well as the two main chemotherapy regimens including duration and side effects.

Content:

- Why do we need adjuvant therapy in stage III colon cancer?

- What is FOLFOX? What is CAPOX? When do we use what?

- What is the optimal duration of therapy?

- What are the characteristics deemed high risk?

- Can we discontinue oxaliplatin early?

- What is the role of oxaliplatin in older patients?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

  continue reading

117 episodes

Artwork
iconShare
 
Manage episode 414306934 series 3377633
Content provided by Ronak Mistry and Rouleaux University Medical Center. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ronak Mistry and Rouleaux University Medical Center or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

This week, we kick off our discussion of adjuvant systemic treatment in colon cancer, beginning with Stage III colon cancer. We will review the evidence basis for adjuvant therapy as well as the two main chemotherapy regimens including duration and side effects.

Content:

- Why do we need adjuvant therapy in stage III colon cancer?

- What is FOLFOX? What is CAPOX? When do we use what?

- What is the optimal duration of therapy?

- What are the characteristics deemed high risk?

- Can we discontinue oxaliplatin early?

- What is the role of oxaliplatin in older patients?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast

  continue reading

117 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide